Location: Washington DC, United States
Date: March 4 to March 8
American Congress of Dermatology.
Updates in Alopecia; Central Centrifugal Cicatricial Alopecia (CCCA): From Fashion to Family History
Melanoma: new diagnostic methods, detection, therapeutic advances
Highlights of the congress
Comments on symposia (vascular birthmarks, esp. hemangiomas)
Prognostic tests for melanoma; Genetic Expression Profiles and other Prognostic Tests for Melanoma: Insights into current and future clinical applications
Metastatic melanoma prognosis, staging and monitoring for dermatologists
Highlights of modern melanoma therapy
What's new in dermatology?
Melanoma: novelties in genetic and molecular testing
Novelties in aesthetic surgery: laser techniques, microneedling, combination of existing techniquies, scar treatment
Results from the UNCOVER-3 Trial: Ixekizumab Treatment in Moderate-to-Severe Plaque Psoriasis
X-Act trial: Omalizumab effectively reduces angioedema episodes in patients with chronic idiopathic/spontaneous urticaria (CIU/CSU)